Negma Group

Navya SA is a prominent French company specializing in autonomous vehicle technology and smart shared mobility solutions. Founded in 2014 and headquartered in Villeurbanne, France, Navya develops, manufactures, and services a range of driverless electric vehicles, including autonomous shuttles and cabs. The company primarily caters to municipalities, industrial sites, universities, theme parks, and airports, and its products are available in the United States, EMEA, and Asia-Pacific regions. Navya has been a pioneer in the autonomous mobility sector, launching its first shuttle, the AUTONOM®SHUTTLE, in 2015, with over 100 units produced and sold in multiple countries. The AUTONOM®CAB, introduced in 2017, is set to undergo road tests soon. With a workforce of more than 200 employees in France and the United States, Navya combines advanced robotic and digital technologies to deliver innovative mobility solutions.

Supply@ME Capital plc is a fintech company based in London that specializes in inventory monetization services for manufacturing and trading firms across Europe. The company has created a proprietary platform designed to facilitate transactions related to inventory monetization, offering an alternative approach to traditional financing methods. With a focus on innovation, Supply@ME aims to help businesses unlock the value of their inventory, thereby enhancing their financial flexibility and operational efficiency.

IGEA Pharma N.V. is a health-tech and med-tech company based in Hoofddorp, the Netherlands, that focuses on developing and commercializing innovative products in the United States. The company offers Alz1, an at-home lab test kit designed to measure non-bound copper levels in the blood, alongside dietary supplements aimed at reducing heavy metal content in the body. Igea Pharma also manufactures dry aerosol generators for sanitizing air and surfaces, as well as devices for air sterilization and purification. With over 20 years of research dedicated to combating Alzheimer’s Disease and diabetes prevention, IGEA Pharma leverages its expertise to provide effective biomedical solutions and laboratory analysis services.